Investor Alert

Company Close Updates Archives | Email alerts

Nov. 17, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 1.64% to $1.20 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.21% to 11,899.34 and Dow Jones Industrial Average DJIA falling 0.56% to 29,783.35. This was the stock's third consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $8.58 below its 52-week high ($9.78), which the company reached on August 31st.

The stock underperformed when compared to some of its competitors Tuesday, as Fate Therapeutics Inc. FATE fell 0.72% to $52.42, Vanda Pharmaceuticals Inc. VNDA rose 0.45% to $13.25, and Viking Therapeutics Inc. VKTX rose 3.22% to $6.42. Trading volume (3.3 M) remained 2.3 million below its 50-day average volume of 5.5 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.